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Background: To analyze the clinicopathologic factors associated with mucosal and submucosal infiltration in
differentiated depressed early gastric cancer, and screening factors that can predict depth of infiltration before
endoscopic treatment.
Methods: The study included 35 cases of mucosal carcinomas and 66 cases of submucosal carcinomas according
to the pathological diagnosis. The relevant clinicopathologic factors were investigated by univariate and
multivariate analysis.
Results: The average depth of the depressed lesions for the submucosal group was significantly more than that for
the mucosal group. The proportion of the lesions with rough bottom surface and abnormal surrounding folds was
significantly higher in the submucosal group compared to that in the mucosal group. Logistic regression analysis
indicated that the above-mentioned three factors were independent risk factors that could be used to predict
mucosal and submucosal infiltration. Area under the curve (AUC) of receiver operating characteristic (ROC) of the
ordinal above-mentioned three factors for predicting submucosal infiltration was 0.716, 0.663, 0.704, respectively.
Stratified analysis showed that the 100% cases with lesion depth ≥2.5 mm and rough bottom surface developed
submucosal infiltration regardless of the morphological changes of the folds.
Conclusion: The study identified independent risk factors for predicting mucosal and submucosal infiltration in
depressed differentiated early gastric cancer, which may evaluate the degree of penetration before endoscopic
treatment.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/13000_2014_206
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Endoscopic mucosal resection (EMR) and endoscopic sub-
mucosal dissection (ESD) have become one of the standard
treatment methods for early-stage gastric cancer in Japan.
The development of these two endoscopic technologies
has benefited from research on two screening criteria for
operability for endoscopic resection. Yamao et al. [1] and
Gotoda et al [2], investigated thousands of patients with* Correspondence: zhanq33@163.com
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unless otherwise stated.early gastric cancer who received gastrectomy and lymph
node dissection, and assessed the clinicopathological
factors for their possible association with lymph node
metastasis. They eventually developed evaluation cri-
teria for EMR and ESD treatment of early gastric cancer
before surgery.
EMR and ESD are therapeutic endoscopic techniques
that offer the advantage of acquiring specimens from the
lesion for pathological analysis. These have become the
most accurate approaches for the diagnosis of early gastric
cancer. For instance, results of the pathological examin-
ation can confirm the cure or suggest additional treat-
ment. The disease-specific 5- and 10-year survival ratesd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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criteria for EMR treatment of early gastric cancer before
surgery [3].
Early gastric ESD offers the advantage of high percent-
age of enbloc resection rates. According to a published
report, enbloc resection rates of 92.7% and curative re-
section rates of 73.6% were achieved [4]. Local recur-
rence of early gastric cancer after ESD treatment was
less than 2% [5]. It is worth noting that the healing ef-
fects similar to those obtained with traditional surgical
treatment could be achieved only if the lesions met the
criteria for curative resection, highlighting the import-
ance of accurate pre and post-operative assessment. The
mistakes in preoperative evaluation do occur (error rate
was 7% in the EMR group and 16% in the ESD group)
and are confirmed by postoperative pathological examin-
ation.4 According to preoperative indications defined by
Japanese Gastric Cancer Association (JGCA) [6,7], endo-
scopic examination and endoscopic biopsy are sufficient
to evaluate the diameter of the lesion, formation of ulcer
and the pathological type of early gastric cancer. How-
ever, practical and putative criteria to evaluate the depth
of mucosal or submucosal infiltration are still lacking.
Given the difficulty in determining the depth of infil-
tration in the depressed early gastric cancer, we followed
the method of Yamao T and Gotoda T [1,2], and retro-
spectively reviewed the clinicopathological characteris-
tics of mucosal and submucosal gastric cancer in order
to identify the factors for preoperative evaluation in gas-
tric cancer.
Methods
Subjects and inclusion/exclusion criteria
Patients who had been diagnosed for depressed early gastric
cancer at Wuxi People’s Hospital Affiliated with Nanjing
Medical University between January 2005 and December
2011 were recruited for this study. The subjects received
surgical resection and lymphadenectomy and the patho-
logical analysis confirmed diagnosis of differentiated type
early gastric cancer. Cases with undifferentiated type early
gastric cancer were excluded due to the controversy sur-
rounding the use of endoscopy for such types of gastric
cancer. All case diagnoses were made by a pathologist
with 16 years clinical experience and confirmed by an in-
dependent pathologist with over 40 years clinical experi-
ence. Informed consents were obtained from all subjects,
and the study was approved by the medical ethics com-
mittee of People’s Hospital of Wuxi, an affiliated hospital
of Nanjing Medical University.
Test parameters
According to the classification of gastric cancer based
on the guidelines laid out by JGCA [7], the lesions
were grouped as: type I (elevated), type II and type III(depressed). Type II can be sub-classified into: type IIa
(surface elevated), type IIb (flat) and type IIc (surface
depressed). Both type III and type IIc were considered
as depressed lesions.
The following clinical data were acquired: (1) gender;
(2) age; (3) location of the lesions (stomach was divided
into upper 1/3, middle 1/3 and lower 1/3 based on
JGCA guidelines;7 (4) size of the lesion (largest diameter
of the bottom surface of depressed area); (5) presence of
ulcer (obvious ulcer or scarring evidence of a previous
ulcer); (6) depth of the lesion (measured as the distance
between planes of the specimen mounted on a pathology
slide from the highest point of the lesion edge to the
lowest point of the lesion basilar portion); (7) bottom of
the lesion: smooth or rough (surface is not flat with
particle-like bulge or small mucosal island); (8) folds
surrounding the lesions: normal folds were marked as
negative and broken folds or enlarged/fusion folds were
marked as positive; (9) degree of gastric cancer differenti-
ation: highly differentiated was defined as grade I cancer
and moderately differentiated was defined as grade II can-
cer; (10) depth of infiltration: the lesions were classified as
mucosal gastric cancer or submucosal gastric cancer.
Statistical analysis
The data were processed using SPSS 17.0 software (SPSS
Inc., Chicago, IL). All the samples were classified into
the mucosal group and the submucosal group based on
the depth of infiltration. T test or Wilcoxon rank test
were used to process quantitative data, and categorical
data were processed by chi-square test. Logistic regres-
sion multiple factor analysis was used to evaluate inde-
pendent factors that influenced the mucosal/submucosal
infiltration of early gastric cancer. Receiver Operating
Characteristic (ROC) curves of independent factors were
plotted based on the above results of Logistic regression
analysis to reflect morphological factors, which may
affect the depth of infiltration. The area under the curve
(AUC) was calculated and cut-off values were estimated.
Stratified analysis was performed for statistically signifi-
cant morphological factors to evaluate the distribution
of mucosal and submucosal groups in various condi-
tions. P < 0.05 was defined as statistically significant.
Results
A total of 101 cases with depressed lesions were evaluated
(35 cases in the mucosal group, 34.7%, Figure 1; 66 cases
in the submucosal group, 65.3%, Figure 2). General patient
information and clinicopathologic data are shown in
Tables 1 and 2.
Univariate analysis of the depressed lesions
Univariate analysis was applied to the data of acquired
characteristics. T test or Wilcoxon rank test were used
Figure 1 A representative moderately differentiated
adenocarcinoma with invasion of the muscular layer of
mucosa. HE staining, low power (40×) microscopic view.






Yes No Yes No
Upper abdominal pain 50 21 19 11
Abdominal distention 41 30 19 11
Decreased food appetite 16 55 5 25
Nausea 25 46 11 19
Vomiting 3 68 3 27
Acid regurgitation 5 66 3 27
Belching 16 55 14 16
Haematemesis 5 66 0 30
Black stool 14 57 0 30
Weight loss 9 62 3 27
Fatigue 7 64 3 27
History of hypertension 27 44 16 14
History of coronary heart disease 5 66 0 30
History of diabetes mellitus 11 60 8 22
History of hepatitis 5 66 0 30
History of cirrhosis 3 68 0 30
Long-term* history of smoking 13 58 0 30
Long-term** history of drinking alcohol 3 68 0 30
Long-term*** oral administration of aspirin 3 68 0 30
Special occupation 3**** 68 0 30
Family history 5 66 3 27
*15-30 years; **7-15 years; ***3-5 years; ****All cases were dust-exposure.
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processed by chi-square test. Results showed that the le-
sion depth of the submucosal group (average 3.9 ±
2.5 mm) was more than that of the mucosal group (aver-
age 2.3 ± 1.5 mm). The analysis of the bottom of the le-
sion showed that the mucosal group had 30 (85.7%)
cases with smooth bottom and 5 (14.3%) cases with
rough bottom, while the submucosal group had 35
(53.0%) cases of smooth bottom and 31 (47.0%) cases of
rough bottom. The analysis of folds surrounding the le-
sions showed that the mucosal group had 27 (77.1%)
cases with normal folds and 8 (22.9%) cases with abnor-
mal folds, while the submucosal group had 24 (36.4%)
cases with normal folds and 42 (63.6%) cases with abnor-
mal folds. The submucosal group showed higher rates
of rough bottom surface and abnormal folds comparedFigure 2 A representative moderately differentiated
adenocarcinoma with invasion of the submucosa. HE staining,
low power (40×) microscopic view.to the mucosal group. The collective data is presented
in Table 3.
Multivariate analysis of depressed lesions
According to the results of univariate analysis, logistic
binary regression model was used to evaluate the size,
depth, bottom surface, and surrounding folds of the le-
sions (P < 0.1). Regression model was established using
forward stepwise regression, and the results obtained
from the three-step regression analysis showed that
depth, surface roughness and surrounding folds of the
lesions are independent predictors of tumor filtration
(Table 4).
Diagnostic performance of independent morphological
factors of the depressed lesions for predicting
submucosal infiltration
We further plotted ROC curves to estimate the diagnos-
tic performance of the three independent predictors:
depth, surface roughness and surrounding folds of the
depressed lesions in gastric cancer (Figure 3). AUCs of
depth, surface roughness and surrounding folds of the
Table 2 Clinical and pathological characteristics of the
patients
Characteristic N Percentage (%)
Sex Male 71 70.3
Female 30 29.7
Age in years 61.2 ± 9.8
Location of lesions Upper 1/3 24 23.8
Middel 1/3 30 29.7
Lower 1/3 47 46.5
Size of the lesions
in mm
15.5 ± 12.3



















Data are presented as N or mean ± SD.
Table 3 Univariate analysis of differentiated depressed early
Factors Values
Mucosal gastric c
Sex Male 24 (66.2)
Female 11 (33.8)
Age in years 62.3 ± 9.2
Lesion location Upper 1/3 6 (17.1)
Middle 1/3 13 (37.2)
Lower 1/3 16 (45.7)
Size of the lesion in mm 12.4 ± 10.8
Ulcer Absence 22 (62.9)
Presence 13 (37.1)
Depth in mm 2.3 ± 1.5
Roughness of the bottom Smooth 30 (85.7)
Rough 5 (14.3)
Surrounding folds Normal 27 (77.1)
Abnormal 8 (22.9)
Degree of differentiation Highly differentiated 4 (11.4)
Moderately differentiated 31 (88.6)
Data are presented as N (%) or mean ± SD.
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(P = 0.007, 95% CI 0.556-0.771) and 0.704 (P = 0.001,
95% CI 0.598-0.810), respectively. The optimal cut-off
value of depth of depressed lesions for predicting sub-
mucosal infiltration was 2.5 mm based on Youden’s
index (Table 5).
Stratified analysis
Based on the cut-off value of 2.5 mm, the lesions were
divided into two groups: <2.5 mm group and ≥2.5 mm
group. Stratified analysis suggested that 100% of the lesions
in early, depressed gastric cancer with depth ≥2.5 mm,
rough bottom surface and normal/abnormal surrounding
folds developed submucosal infiltration (Table 6).
Discussion
Endoscopic mucosal resection (EMR) and endoscopic
submucosal dissection (ESD) are widely accepted endo-
scopic techniques for treating early gastric cancer. The
indications for applying endoscopic therapy are: differen-
tiated type early gastric cancer; no evidence of lymph
node metastasis; infiltration is confined to mucosal or
minute submucosal infiltration [8]. The rate of lymph
node metastasis is less than 3% when the gastric cancer
is confined to mucosal infiltration [9]. However, sub-
mucosal infiltration leads to a higher risk of metastasis
[10]. Due to frequent submucosal infiltration and lymph
node metastasis [11], evaluation of the depth of infiltra-
tion of depressed type of early gastric cancer is crucial
for decisions regarding the therapeutic regimen [8,12].gastric carcinoma
Statistical value p value
ancer Submucosal gastric cancer
47 (71.2) χ2 = 0.076 0.782
19 (28.8)
60.6 ± 10.2 t = 0.402 0.843
18 (27.3) χ2 = 1.994 0.369
17 (25.7)
31 (47.0)
17.2 ± 12.8 U = 894.0 0.061
31 (47.0) χ2 = 2.315 0.128
35 (53.0)
3.9 ± 2.5 U = 656.5 0.000
35 (53.0) χ2 = 10.651 0.001
31 (47.0)
24 (36.4) χ2 = 15.215 0.000
42 (63.6)
6 (9.1) χ2 = 0.140 0.708
60 (90.9)
Table 4 Multivariate analysis of differentiated depressed early gastric carcinoma
B S.E. Wals df Sig. Exp
(B)
Exp (B) 95% CI
Lower limit Upper limit
Lesion depth 0.425 0.151 7.949 1 0.005 1.530 1.138 2.056
Bottom roughness 1.348 0.608 4.918 1 0.027 3.851 1.170 12.681
Surrounding folds 1.448 0.520 7.746 1 0.005 4.254 1.535 11.794
Abbreviations: B regression coefficient, S.E. standard error, Wals the square of the ratio of the regression coefficient and standard error, df degrees of freedom,
Sig probability, Exp (B) the exponential function, and is the result of regression coefficient B value index calculation, CI confidence interval.
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the depth of infiltration. Computed tomography (CT)
scan does not assess the depth of tumor invasion [13].
The use of endoscopic ultrasonography is also contro-
versial in determining the depth of infiltration [14]. A
summary of 18 studies suggested that sensitivity varied
from 18.2% to 100% (average 87.8%) and specificity var-
ied from 34.7% to 100% (average 80.2%) when using
endoscopic ultrasound for the diagnosis of submucosal
invasion of early gastric cancer [15]. It was concluded
that it is not a mature method for differentiating be-
tween mucosal and submucosal infiltration. Tradition-
ally, gastroscopy has been used for early gastric cancer
staging with an accuracy of 79.0%, which is similar to
that achieved by endoscopic ultrasound [16-18]. Thus,
ordinary endoscopy could provide sufficient information
to determine the best treatment options for the resection
of early gastric cancer.
Our study identified independent predictive factors for
infiltration based on the analysis of multiple clinical and
pathomorphological data. We further applied stratifiedFigure 3 ROC curve to predict infiltration depth based on
lesion depth, bottom roughness and surrounding folds.analysis to these factors to predict the depth of filtration.
It was reported that the diameter of the lesion is associ-
ated with the depth of infiltration of gastric cancer [19],
but our results indicated that there was no significant
difference between mucosal and submucosal groups. Be-
sides, only seven cases of depressed lesions among 37
cases of gastric cancer were included [19], which limits
the analysis performed in that study. The parameters,
such as the location of the lesion, presence of ulcer and
histology type are irrelevant to the depth of filtration,
which is consistent with a previously published study
[20]. ROC curve analysis further illustrates the value of
the three factors for the diagnosis of lesion infiltration.
Among the three factors, the depth of the lesion is super-
ior to the lesion bottom roughness and surrounding folds
in term of its value for making a diagnosis. Our findings
that the presence of rough bottom surface and irregular
folds also aid in the diagnosis of submucosal gastric cancer
are in agreement with a pervious study [21].
It should be noted that in this study, the converging
folds were considered as ulcer but not the abnormal
changes of the surrounding folds. Only the broken and
enlarged folds were defined as abnormal folds. The for-
mation of ulcers and subsequent scarring and conver-
ging fold normally indicate tissue fibrosis but do not
necessarily suggest penetration of tumor, although some
gastric cancers with converging folds are confined to theTable 5 ROC curve and Youden’s index based on the
depth of the lesions
Lesion depth Sensitivity Specificity 1—specificity Youden’s indexa
0.000 1.000 0.000 1.000 0.000
1.250 0.864 0.429 0.571 0.293
1.750 0.848 0.429 0.571 0.277
2.500b 0.621 0.714 0.286 0.315
3.500 0.439 0.771 0.229 0.210
4.500 0.409 0.829 0.171 0.238
5.500 0.197 1.000 0.000 0.197
6.000 0.167 1.000 0.000 0.167
7.500 0.121 1.000 0.000 0.121
9.000 0.061 1.000 0.000 0.061
11.000 0.000 1.000 0.000 0.000
aYouden’s index = (sensitivity + specificity)-1; bthe optimal cut-off value.
Table 6 Stratified analysis of the differentiated depressed early gastric carcinoma
Lesion
depth
Bottom roughness Grouping based on penetration depth Sum
Mucosal surface Submucosal surface
< 2.5 mm Smooth Surrounding folds No Count 16 7 23
Percentage 69.5% 31.5% 100.0%
Yes Count 4 6 10
Percentage 40.0% 60.0% 100.0%
Rough Surrounding folds No Count 4 4 8
Percentage 50.0% 50.0% 100.0%
Yes Count 1 8 9
Percentage 11.1% 88.9% 100.0%
≥ 2.5 mm Smooth Surrounding folds No Count 7 11 16
Percentage 43.8% 56.2% 100.0%
Yes Count 3 11 14
Percentage 21.4% 79.6% 100.0%
Rough Surrounding folds No Count 0 2 2
Percentage 0.0% 100.0% 100.0%
Yes Count 0 17 17
Percentage 0.0% 100.0% 100.0%
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large when the top of the folds are infiltrated by the
tumor. If annular dike appears, the tumor may have in-
vaded the muscular layer. Thus, abnormal folds but not
the presence or absence of ulcers may provide useful in-
formation for evaluating the depth of penetration in dif-
ferentiated gastric cancer.
Based on the Youden’s index derived from the ROC
curve, we defined 2.5 mm as the cut-off value to divide the
lesions into two groups (lesion depth <2.5 mm or ≥2.5 mm).
Indeed, cases with lesion depth ≥2.5 mm with rough
bottom surface had 100% submucosal penetration, re-
gardless of the status of the surrounding folds. How-
ever, 69.5% cases with lesion depth <2.5 mm, smooth
bottom and normal surrounding folds were confined
to the mucosa. However, we measured the depth using
specimens mounted on glass slides for pathological
analysis; as such, the distance is expected to have been
affected (shrunk by 10-20%) by the formalin fixation
and dehydration processes that are required for slide
preparation. Our study aimed to reflect the conditions
found under endoscopy and before any biopsy is taken.
Therefore, the cut-off value of 2.5 mm may actually be
3 mm in living stomach. It is important that any future re-
search studies, either from our lab or others, should de-
sign and use measurement methods that will reduce this
kind of error.
Conclusions
Overall, we identified lesion depth, bottom roughness
and surrounding folds as independent predictive factorsfor evaluating mucosal or submucosal infiltration in de-
pressed gastric cancer based on retrospective analysis of
the pathology samples. The results indicate that further
studies from multiple centers and with larger sample sizes
are required.
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